Articles From: Sigma-Aldrich Corporation's Sigma Life Science Business to Distribute Worldwide Olink Bioscience's Protein Interaction Analysis Technology to Targeted Medical Pharma is Assigned Comprehensive Pharmaceutical Billing Patent


2013/2/12
Complements Sigma Life Science's Antibody, RNAi, and Gene Editing Technologies ST.
Sign-up for Sigma-Aldrich Corporation's Sigma Life Science Business to Distribute Worldwide Olink Bioscience's Protein Interaction Analysis Technology investment picks
2013/2/12
Smith Micro Software, Inc .
Sign-up for Smith Micro Launches Integrated Voice and Video Messaging Platform, Opening New Revenue Opportunities for Mobile Network Operators investment picks
2013/2/12
-- Grows earnings per diluted share more than 51% vs.
Sign-up for Snyder's-Lance, Inc. Reports Results for Full Year 2012 investment picks
2013/2/12
BEDFORD, Mass., Feb.
Sign-up for SoundBite Communications Announces Conference Call for Fourth Quarter 2012 Financial Results investment picks
2013/2/12
Spacenet Inc.®, a wholly owned subsidiary of Gilat Satellite Networks Ltd.
Sign-up for Spacenet Awarded Multi-Year Contract with One of the World’s Leading Delivery Service Organizations investment picks
2013/2/12
CHARLOTTE, Mich.
Sign-up for Spartan Motors Reports Fourth Quarter and Full Year 2012 Results Highlighted by Revenue Growth investment picks
2013/2/12
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced it will host a teleconference and webcast with management to discuss the fourth quarter and fiscal year 2012 financial results, provide an update on the Company's business, and discuss expectations for the future.
Sign-up for Spectrum Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2012 Financial Results Teleconference and Webcast investment picks
2013/2/12
Fourth Quarter 2012 - Revenues of $1.426 billion - Operating Income of $98 million, after development program charges - Fully-Diluted Earnings Per Share of $0.43 Full-Year 2012 - Revenues of $5.398 billion - Operating Income of $92 million, after development program charges and benefit of insurance settlement - Fully-Diluted Earnings Per Share of $0.24 - Total backlog of over $35 billion Financial Guidance for Full-Year 2013 - Revenue between $5.8 - $6.0 billion - Fully-Diluted Earnings Per Share between $1.90 - $2.10; Fully-Diluted Earnings Per Share excluding severe weather adjustments between $2.20 - $2.40 * WICHITA, Kan.
Sign-up for Spirit AeroSystems Holdings, Inc. Reports Fourth Quarter and Full-Year 2012 Financial Results investment picks
2013/2/12
Spirit AeroSystems' Fourth Quarter and Full-Year 2012 Financial Results Presentation Replay Available Canada NewsWire WICHITA , Kan., Feb.
Sign-up for Spirit AeroSystems' Fourth Quarter and Full-Year 2012 Financial Results Presentation Replay Available investment picks
2013/2/12
Sportsnet and Vancouver Canucks Announce 10-Year Multiplatform Broadcast Rights Extension Through 2022/23 Canada NewsWire - Sportsnet and Canucks bolster long-standing partnership with landmark multiplatform agreement including television, online and mobile, beginning 2013/14 season - - Sportsnet continues 14-year legacy of delivering Vancouver Canucks hockey; will air up to 60 regular season games each season - - Rogers and Sportsnet continue to invest in sports and premium content to drive future growth - NOTE: Media availability today at 10 a.m. PT , Rogers Arena, Norm Jewison Media Room VANCOUVER , Feb.
Sign-up for Sportsnet and Vancouver Canucks Announce 10-Year Multiplatform Broadcast Rights Extension Through 2022/23 investment picks
2013/2/12
- Sportsnet and Canucks bolster long-standing partnership with landmark multiplatform agreement including television, online and mobile, beginning 2013/14 season - - Sportsnet continues 14-year legacy of delivering Vancouver Canucks hockey; will air up to 60 regular season games each season - - Rogers and Sportsnet continue to invest in sports and premium content to drive future growth - NOTE: Media availability today at 10 a.m. PT , Rogers Arena, Norm Jewison Media Room VANCOUVER , Feb.
Sign-up for Sportsnet and Vancouver Canucks Announce 10-Year Multiplatform Broadcast Rights Extension Through 2022/23 investment picks
2013/2/12
Stanley Black & Decker (NYSE: SWK) , a diversified global provider of power and hand tools, mechanical access solutions, healthcare solutions, electronic security and monitoring systems, and products and services for industrial applications, was recently named Sector Mover following selection as a component of the Dow Jones Sustainability Index for North America for the second year in a row in September of 2012, in recognition of its leadership in economic, environmental, and social programs performance.
Sign-up for Stanley Black & Decker Named A Sector Mover Within The 2012 Dow Jones Sustainability Index For North America investment picks
2013/2/12
GREENWICH, Conn.
Sign-up for Starwood Property Trust Announces Pricing of Convertible Notes investment picks
2013/2/12
SANTA ANA, Calif., Feb.
Sign-up for STEC Responds to Nomination of Dissident Directors for 2013 investment picks
2013/2/12
NASSAU, The Bahamas, Feb.
Sign-up for Steiner Leisure Limited Announces Fourth Quarter 2012 Financial Results on February 27, 2013 investment picks
2013/2/12
NEW YORK, Feb.
Sign-up for Stemline Therapeutics to Present at Leerink Swann and Company Global Healthcare Conference investment picks
2013/2/12
Audible today announced that Stephen King’s riveting, much-discussed essay, “Guns,” is now available for purchase as a $0.99 audio download at Audible.com. Created by Audible Studios, the production arm of Audible.com, the audio edition is narrated by two-time Earphones Award winner Christian Rummel.
Sign-up for Stephen King’s Bestselling Kindle Single “Guns” Now Available as an Audio Download at Audible.com investment picks
2013/2/12
Steve Madden (Nasdaq: SHOO) , a leading designer and marketer of fashion footwear and accessories for women, men and children, today announced that the Company's conference call to review fourth quarter and fiscal year end 2012 financial results will be broadcast live over the Internet on Tuesday, February 26, 2013, at 8:30 a.m. Eastern Time.
Sign-up for Steve Madden Announces Fourth Quarter and Fiscal Year End 2012 Earnings Conference Call investment picks
2013/2/12
http://media.marketwire.com/attachments/201210/94139_STLKLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=984494&ProfileId=051205&sourceType=1 COLORADO SPRINGS, CO --
Sign-up for STL Marketing Group, Inc. Achieves Several Milestones investment picks
2013/2/12
WARREN, Ohio , Feb.
Sign-up for Stoneridge to Present at the BB&T Capital Markets 28th Annual Transportation Services Conference investment picks
2013/2/12
ATLANTA , Feb.
Sign-up for SunTrust Declares Quarterly Dividend investment picks
2013/2/12
Record quarterly revenue of $72.8 million, up 19% y/y Non-GAAP Q4: Operating margin more than doubles to 7.8%; Net income of $4.1 million, or $0.11 per share, up from $1.1 million; Cash from operations of $8.8 million YOKNEAM, Israel , Feb.
Sign-up for Syneron Reports Fourth Quarter and Full Year 2012 Results investment picks
2013/2/12
Systemax Inc. (NYSE:SYX) announced today that David Sprosty will step down as the Chief Executive of the Company’s North American Technology Products Group, effective March 1, 2013.
Sign-up for Systemax Announces Management Change at North American Technology Products Group investment picks
2013/2/12
Taco Bell Corp.
Sign-up for Taco Bell® to Make Major Announcement on Wednesday, Feb. 13 at 11:00 a.m. ET investment picks
2013/2/12
Take-Two Interactive Software, Inc. (NASDAQ: TTWO) today announced that Karl Slatoff, the Company’s Chief Operating Officer, and Lainie Goldstein, its Chief Financial Officer, plan to present at the Wedbush Securities Transformational Technologies Management Access Conference in New York City.
Sign-up for Take-Two Interactive Software, Inc. to Present at Wedbush Transformational Technologies Conference investment picks
2013/2/12
Funds From Operations Increases 16.2% Same Center NOI Increases 6.0% GREENSBORO, N.C. , Feb.
Sign-up for Tanger Reports Year End Results For 2012 investment picks
2013/2/12
Targeted Medical Pharma , Inc. (OTCQB: TRGM) (OTCBB: TRGM) , a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced it has been issued patent number 8370172 from the United States Patent and Trademark Office.
Sign-up for Targeted Medical Pharma is Assigned Comprehensive Pharmaceutical Billing Patent investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Sigma-Aldrich Corporation's Sigma Life Science Business to Distribute Worldwide Olink Bioscience's Protein Interaction Analysis Technology to Targeted Medical Pharma is Assigned Comprehensive Pharmaceutical Billing Patent
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity